INT352496

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.27
First Reported 2011
Last Reported 2011
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 2.47
Pain Relevance 0.59

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transmembrane transport (AVP) cell-cell signaling (AVP) response to stress (AVP)
signal transducer activity (AVP) cytosol (AVP) extracellular space (AVP)
AVP (Homo sapiens)
CRS (Homo sapiens)
Pain Link Frequency Relevance Heat
noradrenaline 4 98.00 Very High Very High Very High
adenocard 28 89.12 High High
cytokine 4 78.92 Quite High
Inflammatory response 2 70.28 Quite High
Catecholamine 2 16.80 Low Low
antagonist 32 5.00 Very Low Very Low Very Low
Dopamine 20 5.00 Very Low Very Low Very Low
cINOD 6 5.00 Very Low Very Low Very Low
ischemia 2 5.00 Very Low Very Low Very Low
beta blocker 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Syndrome 82 100.00 Very High Very High Very High
Pressure And Volume Under Development 8 99.84 Very High Very High Very High
Hypertrophy 4 95.64 Very High Very High Very High
Increased Venous Pressure Under Development 20 94.64 High High
Coronary Heart Disease 4 91.52 High High
Atherosclerosis 4 81.40 Quite High
Stress 8 77.28 Quite High
Necrosis 4 77.00 Quite High
Cancer 2 76.64 Quite High
INFLAMMATION 2 69.92 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Arginine vasopressin (AVP) has also detrimental effects on CRS progression by fluid retention and enhancement of angiotensin II and noradrenaline actions.
AVP Regulation (effects) of Gene_expression (progression) of CRS associated with pressure and volume under development, syndrome and noradrenaline
1) Confidence 0.27 Published 2011 Journal International Journal of Nephrology Section Body Doc Link PMC3010630 Disease Relevance 1.23 Pain Relevance 0.29
Arginine vasopressin (AVP) has also detrimental effects on CRS progression by fluid retention and enhancement of angiotensin II and noradrenaline actions.
vasopressin Regulation (effects) of Gene_expression (progression) of CRS associated with pressure and volume under development, syndrome and noradrenaline
2) Confidence 0.23 Published 2011 Journal International Journal of Nephrology Section Body Doc Link PMC3010630 Disease Relevance 1.24 Pain Relevance 0.29

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox